Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusionShuai Xia, Lu Lu, Yun Zhu et al.|Cell Research|2020Cited by 1.4k
Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluationShuai Xia, Lu Lu, Qiaoshuai Lan et al.|Signal Transduction and Targeted Therapy|2021Cited by 68
A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseasesJie Zhou, Qian Wang, Wei Xu et al.|Acta Pharmaceutica Sinica B|2021Cited by 37
25-Hydroxycholesterol-Conjugated EK1 Peptide with Potent and Broad-Spectrum Inhibitory Activity against SARS-CoV-2, Its Variants of Concern, and Other Human CoronavirusesQiaoshuai Lan, Shibo Jiang, Chao Wang et al.|International Journal of Molecular Sciences|2021Cited by 22
Supercoiling Structure-Based Design of a Trimeric Coiled-Coil Peptide with High Potency against HIV-1 and Human β-Coronavirus InfectionChao Wang, Shibo Jiang, Shuai Xia et al.|Journal of Medicinal Chemistry|2021Cited by 17